Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Clearbridge Health Ltd. ( (SG:1H3) ) has shared an announcement.
Clearbridge Health Limited has entered into a strategic alliance with Guangdong Amoreneg Medicine Research and Development Co. Ltd. (GAMRD) to enhance its operations in regenerative medicine. This agreement involves GAMRD providing consultancy services for Clearbridge’s proposed facility in Hong Kong for processing and storing peripheral blood mononuclear cells, while Clearbridge will distribute GAMRD’s products in designated territories. This collaboration is expected to strengthen Clearbridge’s market position in regenerative medicine and expand its operational capabilities, potentially benefiting stakeholders by offering advanced medical solutions.
More about Clearbridge Health Ltd.
Clearbridge Health Limited is a company incorporated in Singapore, operating in the healthcare industry. The company, along with its subsidiaries, focuses on providing medical and healthcare services, with a particular emphasis on innovative medical technologies and solutions.
Technical Sentiment Signal: Sell
Current Market Cap: S$9.92M
See more data about 1H3 stock on TipRanks’ Stock Analysis page.